Genetic markers of cardiovascular disease in rheumatoid arthritis. - Test2 - elhamkhani - TriplyDB

Genetic markers of cardiovascular disease in rheumatoid arthritis.

Genetic markers of cardiovascular disease in rheumatoid arthritis.

http://www.wikidata.org/entity/Q36165202

about

Generation of Functional Cardiomyocytes from the Synoviocytes of Patients with Rheumatoid Arthritis via Induced Pluripotent Stem Cells Deletion of low molecular weight protein tyrosine phosphatase (Acp1) protects against stress-induced cardiomyopathy.Cardiovascular involvement in autoimmune diseases.Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients.A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis.Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis.Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin.Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis.Associations between asymmetric dimethylarginine, homocysteine, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in rheumatoid arthritis.Enhanced cardiovascular risk in rheumatoid arthritis: elucidation, assessment, and management.Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis.Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced?

P2860

Q27313383-31627C7F-9E11-4309-9D3F-8E205AE0E760 Q30032300-9C9367C2-DE5F-471D-8B52-EF4B47918188 Q34081242-27FCFED7-3C0E-4E68-A352-08B3358DF6CD Q34128912-21C17E60-0A25-4BD5-B7F0-D7854DDD3B72 Q34388576-33F1BC3A-B5E9-4FA3-A7EC-031E2C95FA68 Q35035496-D9732BC8-F59D-4A5C-89C8-136E94FE77E4 Q35139150-D785F7D6-4B77-4148-A91C-225952877813 Q35854740-20760E93-AEF6-4FC5-A46D-0F4C6D64E4F3 Q37699878-7665BB0D-BD82-4D08-904D-FD94F9817C82 Q38804355-9D65A117-2FDA-49D4-BA5A-B4CEE9C869A9 Q40655784-34EBDFD5-E432-447E-B9B3-67AF0BA55C00 Q41102153-F7B663AF-DFEA-481B-9281-1959F34231D8 Q41868896-DFCD79B7-2155-4164-9FF9-86298570B474 Q43407682-50AA599E-BB1C-4B07-8448-162DD0CAA0D9 Q51174739-578A6A01-EDB4-4E52-BF09-467398CB890C

P2860

Genetic markers of cardiovascular disease in rheumatoid arthritis.

http://www.wikidata.org/entity/Q36165202

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Genetic markers of cardiovascular disease in rheumatoid arthritis.

@ast

Genetic markers of cardiovascular disease in rheumatoid arthritis.

@en

type

label

Genetic markers of cardiovascular disease in rheumatoid arthritis.

@ast

Genetic markers of cardiovascular disease in rheumatoid arthritis.

@en

prefLabel

Genetic markers of cardiovascular disease in rheumatoid arthritis.

@ast

Genetic markers of cardiovascular disease in rheumatoid arthritis.

@en

P1433

Q36165202-9FB16C02-34BC-4A6C-BC5C-8DD5C50FA81B

P1476

Q36165202-CACD8177-83C6-49A5-B53D-1288E084CF36

P2093

Q36165202-06320B93-737E-4D82-90A6-0CF2D15C6453

Q36165202-173B3A86-0DA8-45BB-B55C-DB53657B129C

Q36165202-65CDBE51-6E9F-4584-81E9-BE86F7EC64C2

Q36165202-FCBCE280-9077-47BD-95C0-E66EC301FCDB

P275

Q36165202-4EC6CE49-556B-4036-A204-4570649C9EFC

P2860

Q36165202-01AFFDFE-9015-41AA-8778-2429FDCD8F32

Q36165202-02CA6618-D443-4619-A962-1857991AA387

Q36165202-05125A1D-310A-4E4C-B0CE-ACD8C563CC5C

Q36165202-057A1559-62E8-48EA-B114-F2F996363762

Q36165202-06A22182-5A11-4AD0-BE05-0318F8E7400D

Q36165202-0D8AA6C3-E493-4618-805C-2DF3AB84774D

Q36165202-0F2F0F53-0268-47E5-89F5-D980B1FF84A8

Q36165202-106F8C69-CDB2-4B54-88A7-2E0879EAB05B

Q36165202-10E7E8F6-D5AB-4776-A0E3-F448CEE066CF

Q36165202-115D26CF-47E8-437C-800D-4F72EB784C67

P304

Q36165202-6F10B549-37DB-43E9-80C4-E9E108D671DA

P31

Q36165202-CDA128DB-E236-4051-B67F-92A760F28B33

P356

Q36165202-E6DF05C4-0C86-48F1-8BB4-435456BACBF9

P478

Q36165202-2118FCF6-53B4-4FA5-813B-8610DD256AB0

P50

Q36165202-9A5E74AA-7A7D-4C50-B433-1C11A08B87A0

Q36165202-FBC56FEB-1688-4932-988C-34415FABDA03

P5008

Q36165202-4E680D35-5B22-41F8-842F-99168B96B2C6

P577

Q36165202-1A021B70-AC9B-418D-B1CE-00A264B7AA7E

P5875

Q36165202-6CE0BF0E-6BD3-48C8-857C-1B17DB165EC5

P698

Q36165202-94C1B28C-44BF-4D5D-8AB9-24EC1C08BE9E

P921

Q36165202-1CC7D0CD-8ACF-4737-B1B5-2427CB70BBB1

Q36165202-8FC41F76-9F1C-4190-818E-571DC65C6AC8

P932

Q36165202-BA66E72C-9E81-41CF-950C-0F1C5EECA61F

P356

P1433

Mediators of Inflammation

P1476

Genetic markers of cardiovascular disease in rheumatoid arthritis

@en

P2093

Carlos González-Juanatey

http://www.w3.org/2001/XMLSchema#string

Javier Martín

http://www.w3.org/2001/XMLSchema#string

Miguel A González-Gay

http://www.w3.org/2001/XMLSchema#string

Raquel López-Mejías

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

Genomewide association analysis of coronary artery disease

Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis

Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation

Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes

P304

574817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/574817

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

Luis Rodriguez-Rodriguez

M García-Bermúdez

P5008

P577

2012-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230749255

http://www.w3.org/2001/XMLSchema#string

P698

22927710

http://www.w3.org/2001/XMLSchema#string

P921

rheumatoid arthritis

cardiovascular disease

P932

3419432

http://www.w3.org/2001/XMLSchema#string